Key patent obtained for Introgen's Phase 3 product.(Brief Article): An article from: BIOTECH Patent News

This digital document is an article from BIOTECH Patent News, published by Biotech Patent News on July 1, 2002. The length of the article is 628 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Key patent obtained for Introgen's Phase 3 product.(Brief Article)
Publication:BIOTECH Patent News (Newsletter)
Date: July 1, 2002
Publisher: Biotech Patent News
Volume: 16 Issue: 7 Page: NA

Article Type: Brief Article

Distributed by Thomson Gale